[go: up one dir, main page]

FI803200L - Cefalosporinsolvat - Google Patents

Cefalosporinsolvat

Info

Publication number
FI803200L
FI803200L FI803200A FI803200A FI803200L FI 803200 L FI803200 L FI 803200L FI 803200 A FI803200 A FI 803200A FI 803200 A FI803200 A FI 803200A FI 803200 L FI803200 L FI 803200L
Authority
FI
Finland
Prior art keywords
cefalosporinsolvat
Prior art date
Application number
FI803200A
Other languages
English (en)
Other versions
FI803200A7 (fi
Inventor
Billy Grinnell Jackson
Donna Nezich Gardner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI803200L publication Critical patent/FI803200L/fi
Publication of FI803200A7 publication Critical patent/FI803200A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI803200A 1979-10-09 1980-10-09 Kefalosporiinisolvaatteja. FI803200A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/082,822 US4252951A (en) 1979-10-09 1979-10-09 Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
FI803200L true FI803200L (fi) 1981-04-10
FI803200A7 FI803200A7 (fi) 1981-04-10

Family

ID=22173679

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803200A FI803200A7 (fi) 1979-10-09 1980-10-09 Kefalosporiinisolvaatteja.

Country Status (27)

Country Link
US (1) US4252951A (fi)
EP (1) EP0027050B1 (fi)
JP (1) JPS5661388A (fi)
KR (1) KR840000866B1 (fi)
AT (1) AT369008B (fi)
AU (1) AU6306180A (fi)
BE (1) BE885569A (fi)
CA (1) CA1146539A (fi)
CH (1) CH647523A5 (fi)
CS (1) CS215142B2 (fi)
DD (1) DD153375A5 (fi)
DE (1) DE3065181D1 (fi)
DK (1) DK424680A (fi)
ES (1) ES495753A0 (fi)
FI (1) FI803200A7 (fi)
FR (1) FR2467211A1 (fi)
GB (1) GB2059966B (fi)
GR (1) GR70219B (fi)
HU (1) HU183230B (fi)
IE (1) IE50390B1 (fi)
IL (1) IL61227A (fi)
IT (1) IT1132926B (fi)
PH (1) PH15023A (fi)
PT (1) PT71886B (fi)
RO (1) RO80664B (fi)
YU (1) YU256480A (fi)
ZA (1) ZA806192B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588086A (ja) * 1981-07-07 1983-01-18 Takeda Chem Ind Ltd セフアロスポリン溶媒和物およびその製造法
US4426528A (en) 1982-04-01 1984-01-17 Eli Lilly And Company Purification of syn-(2-aminothiazol-4-yl)methoxyimino)acetic acid
JPH08831B2 (ja) * 1985-09-20 1996-01-10 富山化学工業株式会社 セファロスポリンの精製法
JPH07116200B2 (ja) * 1985-09-20 1995-12-13 富山化学工業株式会社 セファロスポリンの製造方法
USD404431S (en) 1997-06-30 1999-01-19 Hilco Corporation Gumball dispenser
ATE397581T1 (de) * 1999-04-06 2008-06-15 Sepracor Inc O-desmethylvenlafaxin-succinat
JP4577751B2 (ja) * 1999-09-02 2010-11-10 塩野義製薬株式会社 芳香族ヘテロ環誘導体を含有するインテグラーゼ阻害剤
CA2284459C (en) 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
AU2001236457A1 (en) * 2000-01-13 2001-07-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DK1372551T3 (da) * 2001-03-08 2009-01-12 Univ Pennsylvania Faciale amphifile polymerer som anti-infektionsmidler
US7842677B2 (en) * 2001-08-29 2010-11-30 Seneb Biosciences, Inc. Synthetic ganglioside derivatives and compositions thereof
AU2003264430B2 (en) * 2002-09-19 2009-03-19 Kyorin Pharmaceutical Co., Ltd. Amino alcohol derivative, addition salt thereof, and immunosuppressant
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
EP2471525A3 (en) 2003-03-17 2012-12-12 The Trustees Of The University Of Pennsylvania Facially amphiphllic polymers and oligomers and uses thereof
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US20050203184A1 (en) 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
CA2554163A1 (en) 2004-01-23 2005-08-11 The Trustees Of The University Of Pennsylvania Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
ZA200609924B (en) * 2004-05-06 2008-12-31 Univ California Substituted enaminones, their derivatives and uses thereof
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
WO2006093813A2 (en) * 2005-02-25 2006-09-08 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA et al. Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
CA2599331A1 (en) * 2005-02-28 2006-09-08 Meiji Dairies Corporation Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals preparation comprising the same
BRPI0614805A2 (pt) * 2005-08-10 2011-04-12 Univ Johns Hopkins poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
MX2008001976A (es) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
KR20080075837A (ko) * 2005-10-28 2008-08-19 아이알엠 엘엘씨 단백질 키나제 억제제로서의 화합물 및 조성물
WO2007063286A2 (en) * 2005-11-29 2007-06-07 Hammersmith Imanet Limited Amidine derivatives for in vivo imaging
ES2288107B1 (es) * 2006-01-27 2008-11-01 Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa.
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
US20090075935A1 (en) * 2006-07-03 2009-03-19 L'oreal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
EA016820B1 (ru) * 2006-12-14 2012-07-30 Тева Фармасьютикал Индастриз, Лтд. Кристаллическое твердое основание разагилина
GB2462235B8 (en) 2007-05-11 2013-03-27 Biotechnology Res Corp Ltd Receptor modulators exhibiting neuroprotective andmemory enhancing activities
US7696383B2 (en) * 2007-06-26 2010-04-13 Solvay Pharmaceuticals B.V. N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
FR2920000B1 (fr) * 2007-08-13 2010-01-29 Oreal Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement
NZ584716A (en) * 2007-10-19 2011-12-22 Janssen Pharmaceutica Nv PIPERIDINYL AND PIPERAZINYL MODULATORS OF gamma-SECRETASE
EP2212277B1 (en) * 2007-10-19 2016-08-31 Janssen Pharmaceutica, N.V. Amine linked modulators of y-secretase
CA2702959C (en) * 2007-10-19 2016-07-26 Janssen Pharmaceutica Nv Carbon linked modulators of .gamma.-secretase
EP2093207A1 (en) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Antiinfective and antitumoral compounds isolated from tropical lianas
US8063249B1 (en) * 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
WO2010017328A2 (en) * 2008-08-06 2010-02-11 Rgo Biosciences Llc Cyclodextrin conjugates
CN102197023B (zh) * 2008-10-22 2015-12-16 奥克塞拉有限公司 治疗眼科疾病和紊乱的化合物
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
WO2010132110A1 (en) 2009-05-14 2010-11-18 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
WO2010138828A2 (en) * 2009-05-29 2010-12-02 Abbott Laboratories Potassium channel modulators
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
WO2012067824A1 (en) 2010-11-16 2012-05-24 Abbott Laboratories Potassium channel modulators
KR101991980B1 (ko) * 2011-09-06 2019-06-21 큐알엔에이, 인크. 소형 분자로 전압-개폐된 나트륨 채널 (SCNxA)의 알파 아단위에 관련된 질환의 치료
US8377946B1 (en) * 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GR63088B (en) 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins

Also Published As

Publication number Publication date
DK424680A (da) 1981-04-10
GB2059966B (en) 1983-09-01
HU183230B (en) 1984-04-28
AU6306180A (en) 1981-04-16
DD153375A5 (de) 1982-01-06
CH647523A5 (fr) 1985-01-31
IL61227A0 (en) 1980-12-31
US4252951A (en) 1981-02-24
IE802086L (en) 1981-04-09
DE3065181D1 (en) 1983-11-10
IT1132926B (it) 1986-07-09
GB2059966A (en) 1981-04-29
KR840000866B1 (ko) 1984-06-20
ES8201166A1 (es) 1981-12-01
CA1146539A (en) 1983-05-17
EP0027050A1 (en) 1981-04-15
FR2467211A1 (fr) 1981-04-17
IL61227A (en) 1983-07-31
FR2467211B1 (fi) 1983-06-10
IT8025200A0 (it) 1980-10-08
ES495753A0 (es) 1981-12-01
EP0027050B1 (en) 1983-10-05
YU256480A (en) 1983-02-28
RO80664A (ro) 1983-02-15
JPS5661388A (en) 1981-05-26
PH15023A (en) 1982-05-13
ZA806192B (en) 1982-05-26
PT71886A (en) 1980-11-01
ATA498080A (de) 1982-04-15
RO80664B (ro) 1983-02-28
IE50390B1 (en) 1986-04-16
PT71886B (en) 1981-08-13
FI803200A7 (fi) 1981-04-10
BE885569A (fr) 1981-04-08
AT369008B (de) 1982-11-25
KR830004314A (ko) 1983-07-09
GR70219B (fi) 1982-08-31
CS215142B2 (en) 1982-07-30

Similar Documents

Publication Publication Date Title
FI802347A7 (fi) Ytterdaeck foer vinterkoerning
FI802088A7 (fi) Vattenloeslig kontaktlimkomposition
FI803200L (fi) Cefalosporinsolvat
FI800055A7 (fi) Kalcineringsfoerfarande och -anordning
FI800157A7 (fi) Glidventil- och kopplingssammansaettning
FI801245A7 (fi) Foeroreningsminskande energibesparande glasframstaellningsapparat
BE881787A (fr) Thermisch geisoleede houder
FI803211L (fi) Foerstaerkt behaollare
FI801654A7 (fi) Vaetskefilter
FI801129A7 (fi) Tryckutjaemnings-trevaegsoeverfoeringsventil
FI65853B (fi) Braennare
DK92480A (da) Metal-keramik-sammenfoejning
FI802119A7 (fi) Partikelartade blekningsblandningar
DK293690A (da) 3-brom-4-fluor-benzaldehyd
FI791745A7 (fi) Foerfarande foer anordning foer prosessreglering
FI803140L (fi) Salivsug
AT383864B (de) Raffstore
DK58880A (da) Insecticidadjuvantsystem
FI802485A7 (fi) Hoegfrekvensreaktionsmassa- och hydraulcylinderenhet
FI793962A7 (fi) Framstaellningsfoerfarande foer spinnull
FI800144A7 (fi) Spikpress
FI801054A7 (fi) Reningsfoerfarande foer ursodesoxikolsyra
FI801341A7 (fi) Foerbaettrat fogkitt
FI792517A7 (fi) Stroemkaella
BE883224A (fr) Pyrazol-triazol -triones antibotrytis

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ELI LILLY AND COMPANY